Literature DB >> 30762649

ACUTE MACULAR AND PERIPAPILLARY ANGIOGRAPHIC CHANGES WITH INTRAVITREAL INJECTIONS.

Alexander Barash1, Toco Y P Chui, Patricia Garcia, Richard B Rosen.   

Abstract

PURPOSE: Intravitreal injections acutely and temporarily increase intraocular pressure (IOP), and this may have cumulative long-term effects including an increased risk for glaucoma surgery. This study was designed to measure retinal perfusion density changes on optical coherence tomography (OCT) angiography and OCT thickness alterations associated with acutely increased IOP after intravitreal injections.
METHODS: Retrospective observational clinical study of 40 eyes (39 patients) with various retinopathies from October 2016 to June 2017 at a tertiary care retina clinic in NYC. Patients were older than 18 years, with vision >20/100, able to fixate and without media opacities precluding OCT angiography, receiving intravitreal bevacizumab or aflibercept for diabetic retinopathy, retinal vein occlusion, macular degeneration, retinal neovascularization, or radiation retinopathy. The 3-mm × 3-mm macular and 4.5-mm × 4.5-mm peripapillary OCT angiography perfusion density, macular OCT thickness, and IOP were measured before and immediately after intravitreal injections. Paired t-test was used to compare preinjection and postinjection values for perfusion density and OCT thickness. Regression analysis was performed for potential effects of baseline IOP, IOP change, and age.
RESULTS: Statistically significant decreases in angiographic perfusion density (P < 0.05) were found in most areas of the superficial and deep layer macular OCT angiography, and the overall optic nerve head and the radial peripapillary capillary layer, preferentially temporal. Macular OCT thickness was significantly decreased in the temporal region and increased in the nasal region. Regression analysis showed relationships between age and decreased superficial macular perfusion. Preinjection IOP was only related to OCT thickness in the fovea. Intraocular pressure change was related only to decreased superficial macular perfusion density.
CONCLUSION: Intravitreal injections produce acute IOP changes that are associated with reduced macular and peripapillary perfusion density. Therefore, it is possible that patients receiving regular intravitreal injections may be sustaining perfusion-related injury to ocular structures that may produce glaucomatous damage to the macula and optic nerve.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 30762649      PMCID: PMC6689457          DOI: 10.1097/IAE.0000000000002433

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   3.975


  11 in total

1.  Comparison of choroidal and optic nerve head blood flow regulation during changes in ocular perfusion pressure.

Authors:  Doreen Schmidl; Agnes Boltz; Semira Kaya; Rene Werkmeister; Nikolaus Dragostinoff; Michael Lasta; Elzbieta Polska; Gerhard Garhöfer; Leopold Schmetterer
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-01       Impact factor: 4.799

2.  Regional vascular density-visual field sensitivity relationship in glaucoma according to disease severity.

Authors:  Joong Won Shin; Jiyun Lee; Junki Kwon; Jaewan Choi; Michael S Kook
Journal:  Br J Ophthalmol       Date:  2017-04-21       Impact factor: 4.638

Review 3.  Optical coherence tomography based angiography [Invited].

Authors:  Chieh-Li Chen; Ruikang K Wang
Journal:  Biomed Opt Express       Date:  2017-01-24       Impact factor: 3.732

4.  Image artefacts in swept-source optical coherence tomography angiography.

Authors:  Khalil Ghasemi Falavarjani; Mayss Al-Sheikh; Handan Akil; Srinivas R Sadda
Journal:  Br J Ophthalmol       Date:  2016-07-20       Impact factor: 4.638

5.  Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.

Authors:  Khalil Ghasemi Falavarjani; Nicholas A Iafe; Jean-Pierre Hubschman; Irena Tsui; Srinivas R Sadda; David Sarraf
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

6.  Influence of Large Intraocular Pressure Reduction on Peripapillary OCT Vessel Density in Ocular Hypertensive and Glaucoma Eyes.

Authors:  Gábor Holló
Journal:  J Glaucoma       Date:  2017-01       Impact factor: 2.503

7.  Projection-Resolved Optical Coherence Tomography Angiography of Macular Retinal Circulation in Glaucoma.

Authors:  Hana L Takusagawa; Liang Liu; Kelly N Ma; Yali Jia; Simon S Gao; Miao Zhang; Beth Edmunds; Mansi Parikh; Shandiz Tehrani; John C Morrison; David Huang
Journal:  Ophthalmology       Date:  2017-07-01       Impact factor: 12.079

8.  Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes.

Authors:  Adeleh Yarmohammadi; Linda M Zangwill; Alberto Diniz-Filho; Min Hee Suh; Patricia Isabel Manalastas; Naeem Fatehee; Siamak Yousefi; Akram Belghith; Luke J Saunders; Felipe A Medeiros; David Huang; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

9.  Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab.

Authors:  Jong Wook Lee; Hoon Park; Jeong Han Choi; Hyun Joo Lee; Sang Woong Moon; Ja Heon Kang; Young Gyun Kim
Journal:  BMC Ophthalmol       Date:  2016-05-31       Impact factor: 2.209

Review 10.  A review of optical coherence tomography angiography (OCTA).

Authors:  Talisa E de Carlo; Andre Romano; Nadia K Waheed; Jay S Duker
Journal:  Int J Retina Vitreous       Date:  2015-04-15
View more
  8 in total

Review 1.  Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy.

Authors:  Irini Chatziralli; Sara Touhami; Maria Vittoria Cicinelli; Chrysa Agapitou; Eleni Dimitriou; George Theodossiadis; Panagiotis Theodossiadis
Journal:  Eye (Lond)       Date:  2021-08-18       Impact factor: 3.775

2.  Morphological and Functional Assessment of the Optic Nerve Head and Retinal Ganglion Cells in Dry vs Chronically Treated Wet Age-Related Macular Degeneration.

Authors:  Małgorzata Wichrowska; Przemysław Wichrowski; Jarosław Kocięcki
Journal:  Clin Ophthalmol       Date:  2022-07-28

3.  Optical Coherence Tomography Angiography Findings after Acute Intraocular Pressure Elevation in Patients with Diabetes Mellitus versus Healthy Subjects.

Authors:  Maryam Ashraf Khorasani; Giancarlo A Garcia; Pasha Anvari; Abbas Habibi; Shahriar Ghasemizadeh; Khalil Ghasemi Falavarjani
Journal:  J Ophthalmic Vis Res       Date:  2022-08-15

4.  Optical Coherence Tomography Angiography: Considerations Regarding Diagnostic Parameters.

Authors:  Touka Banaee
Journal:  J Ophthalmic Vis Res       Date:  2022-08-15

5.  Hemodynamic Effects of Anti-Vascular Endothelial Growth Factor Injections on Optical Coherence Tomography Angiography in Diabetic Macular Edema Eyes.

Authors:  Jessica Song; Bonnie B Huang; Janice X Ong; Nicholas Konopek; Amani A Fawzi
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

6.  Optical Coherence Tomography Angiography of Macular Perfusion Changes after Anti-VEGF Therapy for Diabetic Macular Edema: A Systematic Review.

Authors:  Ayman G Elnahry; Gehad A Elnahry
Journal:  J Diabetes Res       Date:  2021-05-22       Impact factor: 4.011

7.  Evaluation of Changes in Macular Perfusion Detected by Optical Coherence Tomography Angiography following 3 Intravitreal Monthly Bevacizumab Injections for Diabetic Macular Edema in the IMPACT Study.

Authors:  Ayman G Elnahry; Ahmed A Abdel-Kader; Karim A Raafat; Khaled Elrakhawy
Journal:  J Ophthalmol       Date:  2020-04-27       Impact factor: 1.909

8.  Acute and subacute macular and peripapillary angiographic changes in choroidal and retinal blood flow post-intravitreal injections.

Authors:  Nadhini Arumuganathan; Maximilian Robert Justus Wiest; Mario Damiano Toro; Timothy Hamann; Katrin Fasler; Sandrine Anne Zweifel
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.